VC fund profile · evidence-aware directory data
Forbion stages, portfolio and investment profile
European life-sciences venture-capital firm investing across company formation, therapeutics ventures and later-stage biopharma growth. Forbion manages approximately €7.5 billion after its 2026 fundraising.
Keep track of Forbion
Save this profile to your VCT watchlist for a quick return.
Stage-based planning range
$1M–$10M
This is a planning range inferred from stage coverage, not a firm-disclosed check size.
Methodology: Stage bucket inferred from the rounds a fund leads or invests in.
No firm-specific check-size disclosure is recorded.
Investment stages
Leads: Seed, Series A, Series B, Series B+, Series C, Growth
Participates: Seed, Series A, Series B, Series B+, Series C, Growth
Sector focus
healthtech · biotech-life-sciences
Geography
Naarden, Netherlands
Founded 2006
Fund size / AUM
Approximately €7.5B
A separate fund-size evidence record is not yet available.
Portfolio in our directory
None yet
Linked startup profiles
Latest fund vehicle
Not recorded
Vehicle name, size, and vintage are not yet structured.
Recent tracked investment
Not recorded
No dated round explicitly links this fund.
Rounds they lead
Rounds they invest
Last verified: 2026-10-07. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.